Cervical lymph node dissemination of a multirecurrent supratentorial ependymoma
Abstract
Ependymomas are rare central nervous system tumors. Half the patients experience recurrence and total resection is of major importance to obtain the most chance of cure. Thus, some patients undergo several repeated resections which may occasionally be at the origin of dissemination along the neuraxis and exceptionally to extraneural sites. We report the case of a boy who presented a multiple recurrence of his supratentorial ependymoma, first at initial site and then with cervical lymph nodes metastases, highlighting the fact that multiple surgical resections may confer an added risk for hematogeneous and lymphatic dissemination. The impact of adjuvant therapies on this risk is discussed.
##plugins.themes.bootstrap3.article.details##
ependymoma, child, surgical dissemination, extraneural metastases
2. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumors of the central nervous system. Acta Neuropathol 2007; 114(2):97-109.
3. Massimino M, Gandola L, Giangaspero F, et al. Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study. Int J Radiat Oncol Biol Phys 2004; 58(5):1336-1345.
4. Merchant TE, Li C, Xiong X, Kun LE, Boop FA, Sanford RA. Conformal radiotherapy after surgery for pediatric ependymoma: a prospective study. Lancet Oncol 2009; 10(3):258-266.
5. Khatua S, Ramaswamy V, Bouffet E. Current therapy and the evolving molecular landscape of pediatric ependymoma. Eur J Cancer 2017; 70:34-41.
6. Rickert CH. Extraneural metastases of pediatric brain tumors. Acta Neuropathol 2003; 105(4):309‑327.
7. Bademci G, Tun K, Erden E, Evliyaoglu C, Unlu A. Late dissemination of ependymoma: case report. Neurocirugia (Astur) 2007; 18(4):333-336.
8. Newton HB, Henson J, Walker RW. Extraneural metastases in ependymoma. J Neurooncol 1992; 14(2):135-142.
9. Hoffman HJ, Duffner PK. Extraneural metastases of central nervous system tumors. Cancer 1985; 56(7 Suppl):1778-1782.
10. Duffner PK, Cohen ME. Extraneural metastases in childhood brain tumors. Ann Neurol 1981; 10:261-265.
11. Chao M, Packer RJ, Myseros JS, Rood BR. Isolated extracranial recurrence of anaplastic ependymoma. Pediatr Blood Cancer 2011; 56(2):317-318.
12. Dunst J, Klinger M, Thierauf P. Ependymoma with cervical lymph node metastases. Klin Padiatr 1987; 199(1):19-21.
13. Kinoshita M, Izumoto S, Kagawa N, Hashimoto N, Maruno M, Yoshimine T. Long-term control of recurrent anaplastic ependymoma with extracranial metastasis: importance of multiple surgery and stereotactic radiosurgery procedures-case report. Neurol Med Chir 2004; 44:669-673.
14. Varan A, Sari N, Akalan N, et al. Extraneural metastasis in intracranial tumors in children: the experience of a single center. J Neurooncol 2006; 79(2):187-190.
15. Kumar P, Rastogi N, Jain M, Chhabra P. Extraneural metastases in anaplastic ependymoma. J Cancer Res Ther 2007; 3(2):102-104.
16. Hussain M, Mallucci C, Abernethy L, Godhamgaonkar V, Thorp N, Pizer B. Anaplastic ependymoma with sclerotic bone metastases. Pediatr Blood Cancer 2010; 55(6):1204-1206.
17. Fischer C, Haque SS, Huse JT, et al. Extraneural ependymoma: distant bone, lung, liver, and lymph node metastases following bevacizumab. Pediatr Blood Cancer 2013; 60(1):143-145.
18. Vanuytsel LJ, Bessell EM, Ashley SE, Bloom HJ, Brada M. Intracranial ependymoma: long-term results of a policy of surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1992; 23(2):313-319.
19. Fouladi M, Helton K, Dalton J, et al. Clear cell ependymoma: a clinicopathologic and radiographic analysis of 10 patients. Cancer 2003; 98(10):2232-2244.
20. Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 2016; 131(6):803-820.
Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.
Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.
Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.